CesarRodriguez ValdesMD

Hematologic Oncology

Associate Professor, Clinical Director and Operations Myeloma Center of Excellence, Icahn School of Medicine at Mount Sinai

Dr. Rodriguez Valdes is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Office
Icahn School of Medicine at Mount Sinai
1 Gustave L Levy Pl
New York, NY 10029
Phone+1 336-716-5847
Is this information wrong?

University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 2009 - 2012
Texas Tech University Health Sciences Center Paul L. Foster School of MedicineResidency, 2006 - 2009
Monterrey Inst TechClass of 2005
ITESM MD

PubMed

Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethas...
Rebecca Silbermann, Jacob Laubach, Jonathan L Kaufman, Douglas W Sborov, Brandi Reeves, Cesar Rodriguez, Ajai Chari, Luciano J Costa, Larry D Anderson Jr, Nitya Nathwa...> ;American Journal of Hematology. 2024 Apr 15
5 citations
IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies.
Guido Lancman, Kian Parsa, Krzysztof Kotlarz, Lisa Avery, Alaina Lurie, Alex Lieberman-Cribbin, Hearn Jay Cho, Samir S Parekh, Shambavi Richard, Joshua Richter, Adrian...> ;Blood Cancer Discovery. 2023 Nov 1
1 citations
Trial designs and endpoints for immune therapies in multiple myeloma.
Guido Lancman, Erin Moshier, Hearn Jay Cho, Samir Parekh, Shambavi Richard, Joshua Richter, Adriana Rossi, Larysa Sanchez, Sundar Jagannath, Ajai Chari, Rodriguez, C.> ;American Journal of Hematology. 2023 Mar 1